Ibio inc. er et selskap som har en forholdsvis ny 130.000 square feet fabrikk, hovedfokus på fastpharming, forskjellig biologisk til bruk i medisiner samt vaksiner for folk og dyr. FastPharming er å lage vaksiner og proteiner o.l plantebasert og i kjempeskala, labben/fabrikken som sådan skal være ekstra enkel å skalere opp og ned etter nødvendighet, gjerne i forbindelse med pandemier o.l.
Ibio har et samarbeid med Infectious Disease Research Institute.
This partnership circles back to the scalability factor. Infectious Disease Research Institute CEO Corey Casper expressed excitement in facilitating the development of Ibio-200 and [highlighted the synergy between his institute and iBio]
(ibio-200 er VLP vaksinekandidaten mot covid-19 )
“Combining iBio’s VLP antigen with an IDRI adjuvant provides for promising safety and efficacy characteristics, and importantly, the ready ability to scale-up manufacturing to help meet the projected global demand for a suitable vaccine.”
Finansielt 1000% i minus. Så ikkje kjøp bare fordi det finnes en tråd her. Men eg vil se nærmere på den av flere grunner. Kanskje flere fatter interessen 
iBio is an innovator biologics company developing therapeutics and vaccines for the betterment of human and animal health, including a virus-like particle (VLP) -based vaccine against SARS-CoV-2. iBio’s subsidiary, iBio CDMO is a global leader in plant-based manufacturing. It’s FastPharming ™ and FastGlycaneering ™ platforms provide contract development and manufacturing services via its 130,000 square foot facility in Bryan, Texas. The speed and scalability of FastPharming make it an ideal choice for other innovator companies who want to rapidly produce biologics.
The company calls its plant-centered technology FastPharming. This proprietary methodology combines “vertical farming, automated hydroponics, and glycan engineering technologies to rapidly deliver gram quantities of high-quality monoclonal antibodies, vaccines, bioinks and other proteins.”
spennende å følge med videre, den har jammen snudd seg litt rundt, ned nesten 10 prosent så langt idag 
